Organization

CHRU Besançon - Hôpital Jean Minjoz

1 abstract

Abstract
Toxicity profile and discordance between patients/physicians regarding niraparib maintenance in recurrent ovarian cancer (ROC) patients: Lessons from the NIQOLE real-life study—GINECO study.
Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Centre François Baclesse, CHRU Besançon - Hôpital Jean Minjoz, Clinique Tivoli-Ducos, Léon Bérard Cancer Center,